Damora Therapeutics, Inc. — DEF 14A Filings
6 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by Damora Therapeutics, Inc. (DMRA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Damora Therapeutics, Inc. has filed 6 DEF 14A documents with the SEC since 2020. To view all SEC filings by Damora Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
4
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001140361-25-047056 | Dec 31, 2025 | Feb 9, 2026 |
| DEF 14A | DEF 14A | 0000950170-25-060552 | Apr 30, 2025 | Jun 18, 2025 |
| DEF 14A | DEF 14A | 0000950170-24-049811 | Apr 29, 2024 | Jun 20, 2024 |
| DEF 14A | DEF 14A | 0000950170-23-015475 | Apr 28, 2023 | Jun 14, 2023 |
| DEF 14A | DEF 14A | 0000950170-22-006557 | Apr 28, 2022 | — |
| DEF 14A | DEF 14A | 0001564590-21-018763 | Apr 14, 2021 | May 26, 2021 |